SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011807
Filing Date
2018-08-14
Accepted
2018-08-14 16:21:34
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 578301
2 ex3-2.htm EX-3.2 134294
3 ex-31.htm EX-31 34442
4 ex-32.htm EX-32 7965
  Complete submission text file 0001493152-18-011807.txt   2944922

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ocx-20180630.xml EX-101.INS 366760
6 XBRL SCHEMA FILE ocx-20180630.xsd EX-101.SCH 34465
7 XBRL CALCULATION FILE ocx-20180630_cal.xml EX-101.CAL 50336
8 XBRL DEFINITION FILE ocx-20180630_def.xml EX-101.DEF 125029
9 XBRL LABEL FILE ocx-20180630_lab.xml EX-101.LAB 258738
10 XBRL PRESENTATION FILE ocx-20180630_pre.xml EX-101.PRE 203312
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 181017874
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences